SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021. Anthony O. Etyang , Ifedayo Adetifa , Richard Omore , Thomas Misore , Abdhalah K. Ziraba , Maurine A. Ng’oda , Evelyn Gitau , John Gitonga , Daisy Mugo , Bernadette Kutima , Henry Karanja , Monica Toroitich , James Nyagwange , James Tuju , Perpetual Wanjiku , Rashid Aman , Patrick Amoth , Mercy Mwangangi , Kadondi Kasera , Wangari Ng’ang’a , Donald Akech , Antipa Sigilai , Boniface Karia , Angela Karani , Shirine Voller , Charles N. Agoti , Lynette I. Ochola-Oyier , Mark Otiende , Christian Bottomley , Amek Nyaguara , Sophie Uyoga , Katherine Gallagher , Eunice W. Kagucia , Dickens Onyango , Benjamin Tsofa , Joseph Mwangangi , Eric Maitha , Edwine Barasa , Philip Bejon , George M. Warimwe , J. Anthony G. Scott , Ambrose Agweyu PLOS global public health（2022）
摘要
By May 2021 in three broadly representative populations of unvaccinated individuals in Kenya, seroprevalence of anti-SARS-CoV-2 IgG was 25-50%. There was wide variation in cumulative incidence by location and age.
更多 查看译文
关键词
kenyan health, demographic surveillance sites, sars-cov
AI 理解论文
溯源树
样例
